Page last updated: 2024-11-04

suxibuzone and Arthritis, Rheumatoid

suxibuzone has been researched along with Arthritis, Rheumatoid in 4 studies

suxibuzone : A pyrazolidine that is phenylbutazone which is substituted by a 3-carboxypropanoylmethyl group at the 4-position. Suxibuzone is a prodrug for phenylbutazone and is commonly used as an anti-inflammatory drug in horses.

Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.

Research Excerpts

ExcerptRelevanceReference
"One hundred and fifty patients with rheumatoid arthritis received suxibuzone (426 mg/day, equivalent to 300 mg of phenylbutazone), a prodrug of phenylbutazone, or phenylbutazone (300 mg/day) in a six-week double-blind comparison study."9.05A double-blind comparison of phenylbutazone and suxibuzone, a prodrug of phenylbutazone, in rheumatoid arthritis. ( Honma, M; Kageyama, T; Mizushima, Y; Shiokawa, Y, 1983)
"One hundred and fifty patients with rheumatoid arthritis received suxibuzone (426 mg/day, equivalent to 300 mg of phenylbutazone), a prodrug of phenylbutazone, or phenylbutazone (300 mg/day) in a six-week double-blind comparison study."5.05A double-blind comparison of phenylbutazone and suxibuzone, a prodrug of phenylbutazone, in rheumatoid arthritis. ( Honma, M; Kageyama, T; Mizushima, Y; Shiokawa, Y, 1983)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mizushima, Y3
Shiokawa, Y1
Honma, M1
Kageyama, T1
Goebel, KM1
Hahn, E1
Hausmann, L1
Storck, U1
Kaffarnik, H1
Neurath, F1

Trials

3 trials available for suxibuzone and Arthritis, Rheumatoid

ArticleYear
A double-blind comparison of phenylbutazone and suxibuzone, a prodrug of phenylbutazone, in rheumatoid arthritis.
    International journal of tissue reactions, 1983, Volume: 5, Issue:1

    Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Double-Blind Method; Fema

1983
Pro-drugs of non-steroidal anti-inflammatory agents.
    European journal of rheumatology and inflammation, 1983, Volume: 6, Issue:2

    Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Double-Blind Method; Gast

1983
[Current aspects of rheumatoid arthritis].
    Fortschritte der Medizin, 1979, Oct-25, Volume: 97, Issue:40

    Topics: Administration, Oral; Adult; Arthritis, Rheumatoid; Clinical Trials as Topic; Double-Blind Method; D

1979

Other Studies

1 other study available for suxibuzone and Arthritis, Rheumatoid

ArticleYear
Basic and clinical studies of prodrugs of nonsteroidal anti-inflammatory drugs.
    Pharmacology, 1982, Volume: 25 Suppl 1

    Topics: Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Biotransformation; Humans; Indome

1982